Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy

Cholangiocarcinoma (CCA) is an aggressive neoplasia with an increasing incidence and mortality. It is characterized by a strong desmoplastic stroma surrounding cancer cells. Cancer-associated fibroblasts (CAFs) are the main cell type of CCA stroma and they have an important role in modulating cancer...

Full description

Bibliographic Details
Main Authors: Michele Montori, Chiara Scorzoni, Maria Eva Argenziano, Daniele Balducci, Federico De Blasio, Francesco Martini, Tiziana Buono, Antonio Benedetti, Marco Marzioni, Luca Maroni
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/21/6498
_version_ 1797467699628998656
author Michele Montori
Chiara Scorzoni
Maria Eva Argenziano
Daniele Balducci
Federico De Blasio
Francesco Martini
Tiziana Buono
Antonio Benedetti
Marco Marzioni
Luca Maroni
author_facet Michele Montori
Chiara Scorzoni
Maria Eva Argenziano
Daniele Balducci
Federico De Blasio
Francesco Martini
Tiziana Buono
Antonio Benedetti
Marco Marzioni
Luca Maroni
author_sort Michele Montori
collection DOAJ
description Cholangiocarcinoma (CCA) is an aggressive neoplasia with an increasing incidence and mortality. It is characterized by a strong desmoplastic stroma surrounding cancer cells. Cancer-associated fibroblasts (CAFs) are the main cell type of CCA stroma and they have an important role in modulating cancer microenvironments. CAFs originate from multiple lines of cells and mainly consist of fibroblasts and alpha-smooth muscle actin (α-SMA) positive myofibroblast-like cells. The continuous cross-talking between CCA cells and desmoplastic stroma is permitted by CAF biochemical signals, which modulate a number of pathways. Stromal cell-derived factor-1 expression increases CAF recruitment to the tumor reactive stroma and influences apoptotic pathways. The Bcl-2 family protein enhances susceptibility to CAF apoptosis and PDGFRβ induces fibroblast migration and stimulates tumor lymphangiogenesis. Many factors related to CAFs may influence CCA prognosis. For instance, a better prognosis is associated with IL-33 expression and low stromal IL-6 (whose secretion is stimulated by microRNA). In contrast, a worst prognosis is given by the expression of PDGF-D, podoplanin, SDF-1, α-SMA high expression, and periostin. The maturity phenotype has a prognostic relevance too. New therapeutic strategies involving CAFs are currently under study. Promising results are obtained with anti-PlGF therapy, nintedanib (BIBF1120), navitoclax, IPI-926, resveratrol, and controlled hyperthermia.
first_indexed 2024-03-09T18:57:24Z
format Article
id doaj.art-23072d3f469643eda01c293d30032baf
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T18:57:24Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-23072d3f469643eda01c293d30032baf2023-11-24T05:18:40ZengMDPI AGJournal of Clinical Medicine2077-03832022-11-011121649810.3390/jcm11216498Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for TherapyMichele Montori0Chiara Scorzoni1Maria Eva Argenziano2Daniele Balducci3Federico De Blasio4Francesco Martini5Tiziana Buono6Antonio Benedetti7Marco Marzioni8Luca Maroni9Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyClinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, ItalyCholangiocarcinoma (CCA) is an aggressive neoplasia with an increasing incidence and mortality. It is characterized by a strong desmoplastic stroma surrounding cancer cells. Cancer-associated fibroblasts (CAFs) are the main cell type of CCA stroma and they have an important role in modulating cancer microenvironments. CAFs originate from multiple lines of cells and mainly consist of fibroblasts and alpha-smooth muscle actin (α-SMA) positive myofibroblast-like cells. The continuous cross-talking between CCA cells and desmoplastic stroma is permitted by CAF biochemical signals, which modulate a number of pathways. Stromal cell-derived factor-1 expression increases CAF recruitment to the tumor reactive stroma and influences apoptotic pathways. The Bcl-2 family protein enhances susceptibility to CAF apoptosis and PDGFRβ induces fibroblast migration and stimulates tumor lymphangiogenesis. Many factors related to CAFs may influence CCA prognosis. For instance, a better prognosis is associated with IL-33 expression and low stromal IL-6 (whose secretion is stimulated by microRNA). In contrast, a worst prognosis is given by the expression of PDGF-D, podoplanin, SDF-1, α-SMA high expression, and periostin. The maturity phenotype has a prognostic relevance too. New therapeutic strategies involving CAFs are currently under study. Promising results are obtained with anti-PlGF therapy, nintedanib (BIBF1120), navitoclax, IPI-926, resveratrol, and controlled hyperthermia.https://www.mdpi.com/2077-0383/11/21/6498CAFcancer-associated fibroblastcholangiocarcinomadesmoplasiaα-SMAstroma
spellingShingle Michele Montori
Chiara Scorzoni
Maria Eva Argenziano
Daniele Balducci
Federico De Blasio
Francesco Martini
Tiziana Buono
Antonio Benedetti
Marco Marzioni
Luca Maroni
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
Journal of Clinical Medicine
CAF
cancer-associated fibroblast
cholangiocarcinoma
desmoplasia
α-SMA
stroma
title Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
title_full Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
title_fullStr Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
title_full_unstemmed Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
title_short Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
title_sort cancer associated fibroblasts in cholangiocarcinoma current knowledge and possible implications for therapy
topic CAF
cancer-associated fibroblast
cholangiocarcinoma
desmoplasia
α-SMA
stroma
url https://www.mdpi.com/2077-0383/11/21/6498
work_keys_str_mv AT michelemontori cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT chiarascorzoni cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT mariaevaargenziano cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT danielebalducci cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT federicodeblasio cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT francescomartini cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT tizianabuono cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT antoniobenedetti cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT marcomarzioni cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy
AT lucamaroni cancerassociatedfibroblastsincholangiocarcinomacurrentknowledgeandpossibleimplicationsfortherapy